Thrive Earlier Detection
38 Sidney Street
8 articles with Thrive Earlier Detection
Exact Sciences To Acquire Thrive Earlier Detection, Becoming A Leader In Blood-Based, Multi-Cancer Screening
Brings Together Cancer Screening R&D Pioneers to Transform the Future of Cancer Diagnostics and Impact Lives
The deal, which is worth up to $2.15 billion, is expected to close in the first quarter of 2021 and is subject to regulatory approval.
10/2/2020Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Thrive Earlier Detection Corp., a company dedicated to incorporating earlier cancer detection into routine medical care, today announced it has strengthened its leadership team with key appointments. Sam Asgarian, M.D., has been appointed to chief medical officer and Frank Diehl, Ph.D., as executive vice president of product solutions. Dina Ciarimboli, f
Thrive Earlier Detection, headquartered in Cambridge, Massachusetts, closed on a Series B financing worth $257 million.
The study was run by Johns Hopkins University and Geisinger Health, testing more than 10,000 women with no previous history of cancer.
Thrive Earlier Detection Corp., today announced three key executive appointments: Matt Franklin has been appointed chief commercial officer; Sarah Larson, partner and chief human resources officer at Third Rock Ventures, has joined the company’s board of directors; and Semi Trotto has been promoted to
BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.